The spread of drug-resistant bacteria is a global health concern and could once again become a leading cause of mortality. The World Health Organization has flagged carbapenem-resistant Acinetobacter ...
Spanish VC firm Asabys Partners has closed its second fund at €180 million (US$201.3 million), to be invested in seed to ...
China’s National Medical Products Administration (NMPA) has accepted NDAs for Innovent Biologics Inc.’s IL-23p19 antibody ...
In some ways, remote patient monitoring (RPM) came of age during the COVID-19 pandemic, but payers still worry about the ...
A new series of proteolytic targeting chimeras (PROTACs) was designed by Zhejiang University of Technology scientists based ...
Endometrial cancer (EC) accounts for 20% to 30% of most malignant tumors of the female reproductive system, making it one of ...
The FDA has approved Cobenfy, a dual M1/M4 muscarinic agonist that offers a fundamentally different approach to treating ...
Breakthrough – or even better, revolutionary breakthrough – is perhaps the most overused term in drug development. But the ...
Both chambers of the U.S. Congress put aside their election year politicking Sept. 25 long enough to pass a continuing ...
Neuros Medical Inc.’s Altius direct electrical nerve stimulation system significantly reduced pain in 30 minutes and ...
Nine years on from securing $3.84 million for a phase I clinical trial to test the formulation, with results showing it ...
Researchers from Moderna Inc. and affiliated organizations presented preclinical data for the novel mRNA-lipid nanoparticle ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback